Coral Laboratories Ltd

Coral Laboratories Ltd (CORALAB) is a micro-cap Healthcare company valued at ₹187 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Coral Laboratories Ltd last traded at ₹532, modestly down 0.36% on the day.

Recent developments

On 2026-09-30, promoter holding was recorded at 71.51%, showing no significant change in ownership structure. The latest quarter results, ending 2026-06-30, showed a sharp increase in both revenue and net profit compared to the year-ago quarter, suggesting improved operational efficiency.

Financial performance

The company's business is shrinking, with annual revenue falling 25.3% and net profit dropping 32.2% year-over-year. However, the latest quarter saw revenue rise 57.4% and net profit jump 110.5% compared to the same quarter a year earlier, indicating a recent turnaround in performance.

Valuation multiples

The stock trades at 11.9 times earnings, a discount to the Healthcare median of 32.0, 0.96 times book value. It yields 0.4%.

Things to watch

The company's annual net profit margin narrowed by 1.9 percentage points to 19.1%, and its return on equity remains low at 7.8%. The stock is 21.4% below its 52-week high, and the annual net profit has declined significantly, raising concerns about long-term profitability.

Where it stands

Coral Laboratories Ltd's latest quarter results show strong growth, but annual figures indicate a decline in profitability. The stock is trading below its 52-week high, and the net profit margin has contracted, highlighting the tension between recent performance and long-term trends.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.